Interferon therapy reduces the risk for hepatocellular carcinoma.
Brown
J L
JL
Cranfield University Postgraduate Medical School in Gloucester, Gloucestershire Royal Hospital, Gloucester GL1 3NN, UK. j.brown@rmcs.cranfield.ac.uk
D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005838:Genotype; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D012307:Risk Factors; D019562:Viral Load
D000998:Antiviral Agents; D007372:Interferons